Central Trust Company’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Central Trust Company’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-250	Closed	-$4K	–	1287
2018 Q3	$4K	Buy	+250	New	+$4.29K	﹤0.01%	1149

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Central Trust Company's ECYT Position: Q4 2018 in Review

Central Trust Company sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 250 shares — an estimated $4K sold.

Central Trust Company first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $4K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Central Trust Company reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Central Trust Company sold 250 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $4K.
Central Trust Company first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Central Trust Company's Endocyte, Inc. Common Stock position peaked at $4K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Central Trust Company's 13F filing for Q4 2018, filed 8 Jan 2019.